Sex hormones and innate immunity in tuberculosis
结核病中的性激素和先天免疫
基本信息
- 批准号:10186699
- 负责人:
- 金额:$ 19.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-08 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAntimycobacterial AgentsAppearanceAutologousBiologicalBlood specimenCause of DeathCellsChromatinClinicClinicalCommunicable DiseasesComplexDiseaseDisease susceptibilityEnrollmentEpidemiologyEpigenetic ProcessExhibitsFRAP1 geneFemaleGenderGonadal Steroid HormonesGrowthHealthHormonalHormonesHumanImmuneImmunologic MemoryIncidenceInfectionInfection ControlInterventionLinkLipidsLiteratureMemoryMetabolismMusMycobacterium tuberculosisNatural ImmunityOutcomePathogenesisPathway interactionsPlasmaPopulationPostpartum PeriodPredispositionPregnancyPregnant WomenProtein KinasePubertyReportingSamplingSerumSeveritiesSex BiasSex DifferencesSexual MaturationSignal TransductionSolidSpecialistStimulusTestingTimeTuberculosisUniversitiesVaccinationVariantWomanWorkantimicrobialcis-femalecis-maleepidemiology studyexperimental studygenome-widegenotypic sexhormonal contraceptionhormone therapyimmune functionimprovedin vivoinhibitor/antagonistmacrophagemalemenmonocytemortalitymycobacterialperipheral bloodrecruitresponsesexsexual dimorphismstemtransgendertransgender mentransgender womentuberculosis immunity
项目摘要
Incidence and severity of many non-infectious and infectious diseases and vaccination efficacy differ between
men and women. Although these effects could reflect sex (the biological differences between male and female)
or gender (cultural norms associated with being male or female), a large body of evidence supports that these
differences have a biological component. Tuberculosis (TB), a bacterial infectious disease that is one of the top
ten causes of death worldwide, exhibits sex dimorphism. TB is more frequent and severe in men than women;
human and murine studies demonstrate a biological component of the epidemiologically observed sex
dimorphism. The present proposal stems from our surprising observation that human macrophages differentiated
from monocytes ex vivo in absence of autologous serum exhibit sex bias in M. tuberculosis infection control. Sex
bias was also observed in the accumulation of lipid droplets, a feature associated with decreased
antimycobacterial macrophage activity that is regulated by mechanistic target of rapamycin complex 1
(mTORC1) signaling. The present proposal will determine whether sex hormones determine control of M.
tuberculosis infection by inducing epigenetic reprogramming in monocytes/macrophages and involving mTORC1
signaling. The experimental plan stems from considerations derived from our preliminary results and the
literature. First, the absence of autologus serum, and therefore endogenous sex hormones, in the above-
mentioned experiments is consistent with the involvement of memory innate responses in the observed sex bias.
Second, memory innate responses, which protect against TB, are epigenetically regulated. Third, mTORC1
signaling is regulated by sex hormones and also epigenetically. The clinical capacity and expertise at Rutgers
University will provide access to populations that represent a diverse sex steroid hormone milieu: (a) cis-gender
women taking hormonal contraceptives and women enrolled during and after pregnancy at the Rutgers NJMS
OB/GYN clinic; and (b) transgender men and women at the Rutgers Center for Transgender Health. We have
articulated this proposal in two aims. We will leverage variations of plasma levels of sex steroid hormones due
to exogenous administration (Aim 1A) and pregnancy (Aim 1B) to determine relationships between hormonal
levels, epigenetic profiles in immune cells, and control of M. tuberculosis infection. In Aim 2, we will determine
whether the sex bias we observe in the macrophage control of M. tuberculosis infection is mTORC1-dependent.
The results of the proposed work will guide interventional strategies against TB with respect to sex, pregnancy,
and sex steroid hormonal therapy. Moreover, the fundamental and translational implications of the plan are
generalizable to sex bias in many other diseases.
许多非传染性和传染性疾病的发病率和严重程度以及疫苗接种效果在不同国家之间存在差异。
男人和女人尽管这些影响可能反映了性别(男性和女性之间的生物学差异)
或性别(与男性或女性相关的文化规范),大量证据支持这些
差异有生物学的成分。结核病(TB)是一种细菌性传染病,
全球十大死因之一,显示出性别二态性。结核病在男性中比在女性中更为常见和严重;
人类和鼠类研究表明,流行病学观察到的性别存在生物学成分,
二型性目前的建议源于我们惊人的观察,人类巨噬细胞分化
在不存在自体血清的情况下,来自离体单核细胞的单核细胞在M中表现出性别偏倚。结核病感染控制性
在脂滴积累中也观察到偏倚,这是一个与降低
由雷帕霉素复合物1的机制靶点调节的抗分枝杆菌巨噬细胞活性
(mTORC 1)信号传导。目前的建议将确定是否性激素决定控制M。
通过诱导单核细胞/巨噬细胞中的表观遗传重编程并涉及mTORC 1的结核感染
发信号。实验计划源于对我们的初步结果的考虑,
文学首先,在上述病例中,缺乏自体血清,因此缺乏内源性激素-
上述实验与所观察到的性别偏见中的记忆先天反应的参与是一致的。
第二,防止结核病的记忆先天反应是表观遗传调节的。mTORC1
信号传导受性激素和表观遗传学的调节。罗格斯大学的临床能力和专业知识
大学将提供访问人口,代表了一个多样化的性类固醇激素环境:(a)顺性别
服用激素避孕药的妇女和在Rutgers NJMS怀孕期间和怀孕后登记的妇女
OB/GYN诊所;和(B)罗格斯变性人健康中心的变性人男性和女性。我们有
这一建议有两个目的。我们将利用性类固醇激素的血浆水平的变化,
外源性给药(目的1A)和妊娠(目的1B),以确定激素之间的关系
水平,免疫细胞中的表观遗传特征,以及M.肺结核感染。在目标2中,我们将确定
我们在M.结核感染是mTORC 1依赖性的。
拟议工作的结果将指导在性别、怀孕、
和性类固醇激素治疗此外,该计划的基本和转化影响是
可推广到许多其他疾病中的性别偏见。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Laura Gennaro其他文献
MTC28, a novel 28-kilodalton proline-rich secreted antigen specific for the Mycobacterium tuberculosis complex
MTC28,一种新型 28 千道尔顿富含脯氨酸的分泌抗原,对结核分枝杆菌复合体具有特异性
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:3.1
- 作者:
Claudia Manca;Konstantin P. Lyashchenko;R. Colangeli;Maria Laura Gennaro - 通讯作者:
Maria Laura Gennaro
Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis
结核分枝杆菌分泌的新型抗原 MPT63 的分子克隆、纯化和血清学表征
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:3.1
- 作者:
Claudia Manca;Konstantin P. Lyashchenko;H. Wiker;Donatella Usai;Donatella Usai;Roberto Colangeli;Maria Laura Gennaro - 通讯作者:
Maria Laura Gennaro
Maria Laura Gennaro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Laura Gennaro', 18)}}的其他基金
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
- 批准号:
10847827 - 财政年份:2021
- 资助金额:
$ 19.61万 - 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
- 批准号:
10320995 - 财政年份:2021
- 资助金额:
$ 19.61万 - 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
- 批准号:
10273971 - 财政年份:2021
- 资助金额:
$ 19.61万 - 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
- 批准号:
10733696 - 财政年份:2021
- 资助金额:
$ 19.61万 - 项目类别:
Effects of donor plasma and recipient characteristics on convalescent plasma treatment outcome of COVID-19
供体血浆和受体特征对 COVID-19 恢复期血浆治疗结果的影响
- 批准号:
10225219 - 财政年份:2019
- 资助金额:
$ 19.61万 - 项目类别:
Biomarkers for tuberculosis: new questions, new tools
结核病生物标志物:新问题,新工具
- 批准号:
8529930 - 财政年份:2013
- 资助金额:
$ 19.61万 - 项目类别:
FISH-Flow platform for host-based tuberculosis diagnostics
用于基于宿主的结核病诊断的 FISH-Flow 平台
- 批准号:
8895750 - 财政年份:2013
- 资助金额:
$ 19.61万 - 项目类别:
FISH-Flow platform for host-based tuberculosis diagnostics
用于基于宿主的结核病诊断的 FISH-Flow 平台
- 批准号:
9319621 - 财政年份:2013
- 资助金额:
$ 19.61万 - 项目类别:
相似海外基金
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
纳米荧光素酶报告噬菌体用于快速表征下一代抗分枝杆菌药物的耐药性
- 批准号:
10593796 - 财政年份:2023
- 资助金额:
$ 19.61万 - 项目类别:
Mechanistic analysis of the mycobacterial CIII2CIV2 supercomplex by cryoEM to develop new antimycobacterial agents.
通过冷冻电镜对分枝杆菌 CIII2CIV2 超级复合物进行机理分析,以开发新的抗分枝杆菌药物。
- 批准号:
440127 - 财政年份:2020
- 资助金额:
$ 19.61万 - 项目类别:
Studentship Programs
Optimization and Lead Selection of Novel Antimycobacterial Agents
新型抗分枝杆菌药物的优化和先导筛选
- 批准号:
8714157 - 财政年份:2014
- 资助金额:
$ 19.61万 - 项目类别: